1. Home
  2. IMNN vs ELOG Comparison

IMNN vs ELOG Comparison

Compare IMNN & ELOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$1.47

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

HOLD

Current Price

$0.49

Market Cap

9.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNN
ELOG
Founded
1982
2006
Country
United States
China
Employees
20
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Integrated Freight & Logistics
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
9.0M
IPO Year
2000
2024

Fundamental Metrics

Financial Performance
Metric
IMNN
ELOG
Price
$1.47
$0.49
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
110.3K
108.4K
Earning Date
05-14-2026
07-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.84
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$0.40
52 Week High
$5.55
$3.07

Technical Indicators

Market Signals
Indicator
IMNN
ELOG
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
IMNN
ELOG

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

Share on Social Networks: